enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Intuitive Surgical - Wikipedia

    en.wikipedia.org/wiki/Intuitive_Surgical

    In 2001, the FDA approved use of the system for prostate surgery. The FDA has subsequently approved the system for thoracoscopic surgery, cardiac procedures performed with adjunctive incisions, and gynecologic procedures. [6] Shortly before going public, Intuitive Surgical was sued for patent infringement by Computer Motion, Inc, its chief rival.

  3. Pozelimab - Wikipedia

    en.wikipedia.org/wiki/Pozelimab

    Pozelimab was approved for medical use in the United States in August 2023. [ 3 ] [ 4 ] It is the first FDA-approved treatment for CHAPLE disease. [ 3 ] [ 5 ] The US Food and Drug Administration (FDA) considers it to be a first-in-class medication .

  4. Mazor Robotics - Wikipedia

    en.wikipedia.org/wiki/Mazor_Robotics

    The very first Mazor Robotics product, Spine Assist, was approved by the FDA in 2004. [2] Renaissance Guidance System, Mazor's next generation product, was released commercially in 2011. [ 3 ]

  5. VIVE: 12-Month SUI Feasibility Study Data Further Supports ...

    www.aol.com/news/vive-12-month-sui-feasibility...

    In addition to raising nearly $19M (net) via the sale of common shares, they recently announced compelling 12-month results from their n=36 SUI feasibility study and got the green light from FDA ...

  6. Corneal cross-linking - Wikipedia

    en.wikipedia.org/wiki/Corneal_cross-linking

    Based on three 12-month clinical trials, the US Food and Drug Administration approved riboflavin ophthalmic solution and Avedro's KXL system for crosslinking on 18 April 2016, for the treatment of progressive keratoconus, and on 19 July 2016, for corneal ectasia after refractive surgery, making them the first FDA approved treatment for ...

  7. Lilly's weight-loss treatment Zepbound becomes first FDA ...

    www.aol.com/news/lillys-weight-loss-drug-zep...

    The approval opens up a wide market of patients for Lilly at a time when demand for Zepbound is already surging. Lilly's weight-loss treatment Zepbound becomes first FDA-approved drug for sleep ...

  8. Merck's Experimental Favezelimab/Keytruda Combo Fails ... - AOL

    www.aol.com/mercks-experimental-favezelimab...

    Also Read: Merck’s Keytruda Secures First FDA-Approval For Rare Form Aggressive Cancer. At the final pre-specified analysis, the f. On Wednesday, Merck & Co Inc (NYSE:MRK) released topline data ...

  9. Sufentanil - Wikipedia

    en.wikipedia.org/wiki/Sufentanil

    Sufentanil offers properties of sedation and can be used as analgesic component of anesthetic regimen during an operation. [9]Because of its extremely high potency, it is often used in surgery and post-operative pain management for patients that are heavily opioid dependent/opioid tolerant because of long term opiate use for chronic pain or illicit opiate use.